CN1110485C - 1-芳基磺酰基、芳基(硫代)羰基-哒嗪子基衍生物及其制法 - Google Patents
1-芳基磺酰基、芳基(硫代)羰基-哒嗪子基衍生物及其制法 Download PDFInfo
- Publication number
- CN1110485C CN1110485C CN96199481A CN96199481A CN1110485C CN 1110485 C CN1110485 C CN 1110485C CN 96199481 A CN96199481 A CN 96199481A CN 96199481 A CN96199481 A CN 96199481A CN 1110485 C CN1110485 C CN 1110485C
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- diaza
- compound
- dichloro
- phenanthrene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/36—Benzo-cinnolines
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US790095P | 1995-11-06 | 1995-11-06 | |
US60/007,900 | 1995-11-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1207091A CN1207091A (zh) | 1999-02-03 |
CN1110485C true CN1110485C (zh) | 2003-06-04 |
Family
ID=21728709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96199481A Expired - Fee Related CN1110485C (zh) | 1995-11-06 | 1996-10-10 | 1-芳基磺酰基、芳基(硫代)羰基-哒嗪子基衍生物及其制法 |
Country Status (17)
Country | Link |
---|---|
JP (1) | JP2000501073A (ko) |
KR (1) | KR100360614B1 (ko) |
CN (1) | CN1110485C (ko) |
AU (1) | AU704507B2 (ko) |
BR (1) | BR9611407A (ko) |
CZ (1) | CZ286789B6 (ko) |
HU (1) | HU225162B1 (ko) |
IL (1) | IL124320A (ko) |
MX (1) | MX9803605A (ko) |
NO (1) | NO310460B1 (ko) |
NZ (1) | NZ319979A (ko) |
PL (1) | PL185618B1 (ko) |
RU (1) | RU2175969C2 (ko) |
TW (1) | TW460467B (ko) |
UA (1) | UA48989C2 (ko) |
WO (1) | WO1997017332A1 (ko) |
ZA (1) | ZA969298B (ko) |
-
1996
- 1996-10-10 WO PCT/US1996/016227 patent/WO1997017332A1/en active IP Right Grant
- 1996-10-10 KR KR10-1998-0703345A patent/KR100360614B1/ko not_active IP Right Cessation
- 1996-10-10 NZ NZ319979A patent/NZ319979A/xx unknown
- 1996-10-10 JP JP9518177A patent/JP2000501073A/ja not_active Ceased
- 1996-10-10 CZ CZ19981380A patent/CZ286789B6/cs not_active IP Right Cessation
- 1996-10-10 PL PL96326669A patent/PL185618B1/pl not_active IP Right Cessation
- 1996-10-10 AU AU72637/96A patent/AU704507B2/en not_active Ceased
- 1996-10-10 UA UA98052267A patent/UA48989C2/uk unknown
- 1996-10-10 RU RU98110813/04A patent/RU2175969C2/ru not_active IP Right Cessation
- 1996-10-10 BR BR9611407-0A patent/BR9611407A/pt not_active Application Discontinuation
- 1996-10-10 IL IL12432096A patent/IL124320A/en not_active IP Right Cessation
- 1996-10-10 CN CN96199481A patent/CN1110485C/zh not_active Expired - Fee Related
- 1996-10-10 HU HU0201305A patent/HU225162B1/hu not_active IP Right Cessation
- 1996-11-05 ZA ZA9609298A patent/ZA969298B/xx unknown
- 1996-11-25 TW TW085114479A patent/TW460467B/zh not_active IP Right Cessation
-
1998
- 1998-05-05 NO NO19982030A patent/NO310460B1/no unknown
- 1998-05-06 MX MX9803605A patent/MX9803605A/es not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
J.MED.CHEM.VOL14,NO3 1971-01-01 H.HOLAVAJR.ETAL * |
Also Published As
Publication number | Publication date |
---|---|
HUP0201305A3 (en) | 2003-02-28 |
TW460467B (en) | 2001-10-21 |
AU7263796A (en) | 1997-05-29 |
PL326669A1 (en) | 1998-10-12 |
NZ319979A (en) | 1999-11-29 |
HUP0201305A2 (hu) | 2002-12-28 |
NO982030L (no) | 1998-06-23 |
PL185618B1 (pl) | 2003-06-30 |
NO982030D0 (no) | 1998-05-05 |
IL124320A0 (en) | 1998-12-06 |
AU704507B2 (en) | 1999-04-22 |
JP2000501073A (ja) | 2000-02-02 |
UA48989C2 (uk) | 2002-09-16 |
ZA969298B (en) | 1998-05-05 |
RU2175969C2 (ru) | 2001-11-20 |
HU225162B1 (en) | 2006-07-28 |
CN1207091A (zh) | 1999-02-03 |
KR100360614B1 (ko) | 2003-06-02 |
KR19990067340A (ko) | 1999-08-16 |
CZ286789B6 (en) | 2000-07-12 |
NO310460B1 (no) | 2001-07-09 |
IL124320A (en) | 2001-10-31 |
CZ138098A3 (cs) | 1998-09-16 |
BR9611407A (pt) | 1999-12-28 |
MX9803605A (es) | 1998-09-30 |
WO1997017332A1 (en) | 1997-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1349531A (zh) | 作为黄体酮受体激动剂的氰基吡咯类 | |
CN1042537A (zh) | 喹诺酮衍生物 | |
WO1993011115A2 (en) | Quinolone derivatives and their use as nmda and ampa receptor antagonists | |
JP2003523353A (ja) | アルファ−2−アドレナリン受容体アンタゴニストとしての、1,3−二置換ピロリジン | |
CN1337958A (zh) | 调节雌激素受体的化合物和方法 | |
CN1126473A (zh) | 化学组合物 | |
CN1219170A (zh) | 取代的1,2,3,4-四氢化萘衍生物 | |
CN1228775A (zh) | 作为时间生物学药物的苯并呋喃和苯并吡喃 | |
CN1399633A (zh) | 嘧啶衍生物 | |
EP2265582B1 (fr) | Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique. | |
CN85101761A (zh) | 新型色胺衍生物的制备方法和应用 | |
KR20010024087A (ko) | 모노아민 옥시다제 억제제 및 h5-HT1B 길항제 또는부분 작용제의 배합물 | |
CN1073171A (zh) | 喹啉衍生物、其制备方法及其在治疗中的应用 | |
CN1278809A (zh) | 取代的苯并二氢吡喃衍生物 | |
CN1152874C (zh) | 抗精神病的4-(1h-吲哚基-1-基)-1-取代哌啶衍生物 | |
CN1147485C (zh) | 用作5-ht-2c受体拮抗剂的二氢吲哚衍生物 | |
CN1166623C (zh) | 2-苯氧基苯胺类衍生物 | |
CN1882564A (zh) | 调节类香草素-1受体(vr1)功能的吲唑-3-酮及其类似物和衍生物 | |
CN1110485C (zh) | 1-芳基磺酰基、芳基(硫代)羰基-哒嗪子基衍生物及其制法 | |
CN1259944A (zh) | 选择性的雌激素受体调节剂用于治疗或预防前列腺癌及良性前列腺增生 | |
CN1194983A (zh) | 新的2-氨基-1,2-二氢化茚化合物其制备方法和药物组合物 | |
CA2307114A1 (en) | Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d.alpha. antagonists | |
CN1429223A (zh) | 新颖苯并呋喃衍生物 | |
CN1321158A (zh) | 作为药物的三环△3-哌啶 | |
DE60117517T2 (de) | Indolderivate als mcp-1 rezeptor antagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |